{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T11:53:41Z","timestamp":1780401221404,"version":"3.54.1"},"reference-count":60,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,12,4]],"date-time":"2019-12-04T00:00:00Z","timestamp":1575417600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012021","name":"Iran University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012021","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003968","name":"Iran National Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003967","name":"Iran's National Elites Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003967","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"DOI":"10.3389\/fonc.2019.01302","type":"journal-article","created":{"date-parts":[[2019,12,4]],"date-time":"2019-12-04T04:56:08Z","timestamp":1575435368000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Spheroid-Derived Cells From Renal Adenocarcinoma Have Low Telomerase Activity and High Stem-Like and Invasive Characteristics"],"prefix":"10.3389","volume":"9","author":[{"given":"Leili","family":"Saeednejad Zanjani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Madjd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arezoo","family":"Rasti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mojgan","family":"Asgari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Abolhasani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin J.","family":"Tam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raheleh","family":"Roudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunhild Mari","family":"M\u00e6landsmo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d8ystein","family":"Fodstad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne","family":"Andersson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,12,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/nrurol.2014.194","article-title":"Landmarks in the diagnosis and treatment of renal cell carcinoma","volume":"11","author":"Bhatt","year":"2014","journal-title":"Nat Rev Urol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"151","DOI":"10.6004\/jnccn.2015.0022","article-title":"Kidney cancer, version 3","volume":"13","author":"Motzer","year":"2015","journal-title":"J Natl Comprehens Cancer Netw."},{"key":"B3","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21442","article-title":"Cancer statistics, 2018","volume":"68","author":"Siegel","year":"2018","journal-title":"CA Cancer J Clin."},{"key":"B4","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s11864-003-0039-2","article-title":"Metastatic renal cell carcinoma","volume":"4","author":"Flanigan","year":"2003","journal-title":"Curr Treat Options Oncol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.clgc.2013.11.020","article-title":"A phase Ib study of combined VEGFR and mTOR inhibition with vatalanib and everolimus in patients with advanced renal cell carcinoma","volume":"12","author":"Bitting","year":"2014","journal-title":"Clin Genitourin Cancer."},{"key":"B6","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/nrc3184","article-title":"Cancer stem cells: an evolving concept","volume":"12","author":"Nguyen","year":"2012","journal-title":"Nat Rev Cancer."},{"key":"B7","doi-asserted-by":"publisher","first-page":"3696","DOI":"10.1096\/fj.08-102590","article-title":"Identification of a tumor-initiating stem cell population in human renal carcinomas","volume":"22","author":"Bussolati","year":"2008","journal-title":"FASEB J."},{"key":"B8","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1096\/fj.12-218222","article-title":"Cancer stem cells in solid tumors: an overview and new approaches for their isolation and characterization","volume":"27","author":"Tirino","year":"2013","journal-title":"FASEB J."},{"key":"B9","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/nature03128","article-title":"Identification of human brain tumour initiating cells","volume":"432","author":"Singh","year":"2004","journal-title":"Nature."},{"key":"B10","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1593\/neo.05394","article-title":"Stem-like cells in bone sarcomas: implications for tumorigenesis","volume":"7","author":"Gibbs","year":"2005","journal-title":"Neoplasia."},{"key":"B11","doi-asserted-by":"publisher","first-page":"5506","DOI":"10.1158\/0008-5472.CAN-05-0626","article-title":"Isolation and in vitro propagation of tumorigenic breast cancer cells with stem\/progenitor cell properties","volume":"65","author":"Ponti","year":"2005","journal-title":"Cancer Res."},{"key":"B12","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.canlet.2010.08.013","article-title":"Spheres derived from the human SK-RC-42 renal cell carcinoma cell line are enriched in cancer stem cells","volume":"299","author":"Zhong","year":"2010","journal-title":"Cancer Lett."},{"key":"B13","doi-asserted-by":"publisher","first-page":"5567","DOI":"10.18632\/oncotarget.1901","article-title":"miR-17 inhibition enhances the formation of kidney cancer spheres with stem cell\/tumor initiating cell properties","volume":"6","author":"Lichner","year":"2015","journal-title":"Oncotarget."},{"key":"B14","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/nrc862","article-title":"Telomerase beyond telomeres","volume":"2","author":"Blasco","year":"2002","journal-title":"Nat Rev Cancer."},{"key":"B15","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.mad.2007.10.008","article-title":"Physiological assembly and activity of human telomerase complexes","volume":"129","author":"Collins","year":"2008","journal-title":"Mech Ageing Dev."},{"key":"B16","doi-asserted-by":"publisher","first-page":"3819","DOI":"10.1016\/j.febslet.2010.05.026","article-title":"Telomeres and telomerase in normal and cancer stem cells","volume":"584","author":"Shay","year":"2010","journal-title":"FEBS Lett."},{"key":"B17","doi-asserted-by":"publisher","first-page":"2420","DOI":"10.1101\/gad.271783.115","article-title":"High telomerase is a hallmark of undifferentiated spermatogonia and is required for maintenance of male germline stem cells","volume":"29","author":"Pech","year":"2015","journal-title":"Genes Dev."},{"key":"B18","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/S0959-8049(97)00062-2","article-title":"A survey of telomerase activity in human cancer","volume":"33","author":"Shay","year":"1997","journal-title":"Eur J Cancer."},{"key":"B19","doi-asserted-by":"publisher","first-page":"12606","DOI":"10.1073\/pnas.182407599","article-title":"Telomerase contributes to tumorigenesis by a telomere length-independent mechanism","volume":"99","author":"Stewart","year":"2002","journal-title":"Proc Natl Acad Sci USA."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1016\/j.ejca.2006.01.040","article-title":"Telomeres and telomerase in cancer stem cells","volume":"42","author":"Ju","year":"2006","journal-title":"Eur J Cancer."},{"key":"B21","doi-asserted-by":"publisher","first-page":"11843","DOI":"10.1007\/s13277-016-5041-y","article-title":"Evidence for embryonic stem-like signature and epithelial-mesenchymal transition features in the spheroid cells derived from lung adenocarcinoma","volume":"37","author":"Roudi","year":"2016","journal-title":"Tumor Biol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"e75463","DOI":"10.1371\/journal.pone.0075463","article-title":"Aldehyde dehydrogenase 1 identifies cells with cancer stem cell-like properties in a human renal cell carcinoma cell line","volume":"8","author":"Ueda","year":"2013","journal-title":"PLoS ONE."},{"key":"B23","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/cjp2.91","article-title":"Biomarker discovery for renal cancer stem cells","volume":"4","author":"Corro","year":"2018","journal-title":"J Pathol Clin Res."},{"key":"B24","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.molmed.2008.08.003","article-title":"Cancer stem cell markers in common cancers\u2013therapeutic implications","volume":"14","author":"Klonisch","year":"2008","journal-title":"Trends Mol Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.yexmp.2017.10.001","article-title":"Cytoplasmic expression of CD133 stemness marker is associated with tumor aggressiveness in clear cell renal cell carcinoma","volume":"103","author":"Zanjani","year":"2017","journal-title":"Exp Mol Pathol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.pathol.2018.08.019","article-title":"Human telomerase reverse transcriptase protein expression predicts tumour aggressiveness and survival in patients with clear cell renal cell carcinoma","volume":"51","author":"Zanjani","year":"2018","journal-title":"Pathology."},{"key":"B27","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1093\/gerona\/62.4.367","article-title":"Telomere dynamics in macaques and humans","volume":"62","author":"Gardner","year":"2007","journal-title":"J Gerontol Ser Biol Sci Med Sci."},{"key":"B28","first-page":"657","article-title":"Telomere shortening and growth inhibition of human cancer cells by novel synthetic telomerase inhibitors MST-312, MST-295, and MST-1991","volume":"1","author":"Seimiya","year":"2002","journal-title":"Mol. Cancer Ther."},{"key":"B29","doi-asserted-by":"publisher","first-page":"487","DOI":"10.3892\/ijo.2016.3546","article-title":"Combination treatment with flavonoid morin and telomerase inhibitor MST-312 reduces cancer stem cell traits by targeting STAT3 and telomerase","volume":"49","author":"Chung","year":"2016","journal-title":"Int J Oncol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1056\/NEJMoa065044","article-title":"Sunitinib versus interferon alfa in metastatic renal-cell carcinoma","volume":"356","author":"Motzer","year":"2007","journal-title":"N Engl J Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"3312","DOI":"10.1200\/JCO.2008.19.5511","article-title":"Sorafenib for treatment of renal cell carcinoma: final efficacy and safety results of the phase III treatment approaches in renal cancer global evaluation trial","volume":"27","author":"Escudier","year":"2009","journal-title":"J Clin Oncol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.ejphar.2014.11.021","article-title":"Elacridar enhances the cytotoxic effects of sunitinib and prevents multidrug resistance in renal carcinoma cells","volume":"746","author":"Sato","year":"2015","journal-title":"Eur J Pharmacol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"284581","DOI":"10.1155\/2010\/284581","article-title":"Immunotherapy for renal cell carcinoma","volume":"2010","author":"Itsumi","year":"2011","journal-title":"Clin Develop Immunol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1172\/JCI41004","article-title":"The therapeutic promise of the cancer stem cell concept","volume":"120","author":"Frank","year":"2010","journal-title":"J Clin Invest."},{"key":"B35","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.canlet.2012.05.007","article-title":"Human renal cancer stem cells","volume":"338","author":"Bussolati","year":"2013","journal-title":"Cancer Lett."},{"key":"B36","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1002\/stem.2021","article-title":"Development of a fluorescent reporter system to delineate cancer stem cells in triple-negative breast cancer","volume":"33","author":"Thiagarajan","year":"2015","journal-title":"Stem Cells."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1126\/science.1171837","article-title":"The increasing complexity of the cancer stem cell paradigm","volume":"324","author":"Rosen","year":"2009","journal-title":"Science."},{"key":"B38","doi-asserted-by":"publisher","first-page":"3113","DOI":"10.1158\/1078-0432.CCR-09-2824","article-title":"Cancer stem cells and self-renewal","volume":"16","author":"O'Brien","year":"2010","journal-title":"Clin Cancer Res."},{"key":"B39","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/j.biocel.2013.02.006","article-title":"LIN28\/LIN28B: an emerging oncogenic driver in cancer stem cells","volume":"45","author":"Zhou","year":"2013","journal-title":"Int J Biochem Cell Biol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.4252\/wjsc.v7.i9.1150","article-title":"Common stemness regulators of embryonic and cancer stem cells","volume":"7","author":"Hadjimichael","year":"2015","journal-title":"World J Stem Cells."},{"key":"B41","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1111\/cas.12691","article-title":"Nestin as a marker of cancer stem cells","volume":"106","author":"Neradil","year":"2015","journal-title":"Cancer Sci."},{"key":"B42","doi-asserted-by":"publisher","first-page":"2973","DOI":"10.2147\/OTT.S91863","article-title":"Links between cancer stem cells and epithelial\u2013mesenchymal transition","volume":"8","author":"Wang","year":"2015","journal-title":"Onco Targets Ther."},{"key":"B43","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1158\/0008-5472.CAN-10-2330","article-title":"Snail2 is an essential mediator of Twist1-induced epithelial mesenchymal transition and metastasis","volume":"71","author":"Casas","year":"2011","journal-title":"Cancer Res."},{"key":"B44","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.ccr.2008.06.005","article-title":"Induction of EMT by twist proteins as a collateral effect of tumor-promoting inactivation of premature senescence","volume":"14","author":"Ansieau","year":"2008","journal-title":"Cancer Cell."},{"key":"B45","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1080\/01926230701320337","article-title":"Apoptosis: a review of programmed cell death","volume":"35","author":"Elmore","year":"2007","journal-title":"Toxicol Pathol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/0471141755.ph1425s61","article-title":"Overview of cancer stem cells (CSCs) and mechanisms of their regulation: implications for cancer therapy","volume":"14","author":"Bao","year":"2013","journal-title":"Curr Protocol Pharmacol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/nrg3185","article-title":"Insights into the regulation of protein abundance from proteomic and transcriptomic analyses","volume":"13","author":"Vogel","year":"2012","journal-title":"Nat Rev Genet."},{"key":"B48","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s11010-009-0153-y","article-title":"Telomerase downregulation in cancer brain stem cell","volume":"331","author":"Shervington","year":"2009","journal-title":"Mol Cell Biochem."},{"key":"B49","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/sj.leu.2404141","article-title":"hTERT, the catalytic component of telomerase, is downregulated in the haematopoietic stem cells of patients with chronic myeloid leukaemia","volume":"20","author":"Campbell","year":"2006","journal-title":"Leukemia."},{"key":"B50","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1634\/stemcells.2007-0628","article-title":"Downregulation of multiple stress defense mechanisms during differentiation of human embryonic stem cells","volume":"26","author":"Saretzki","year":"2008","journal-title":"Stem Cells."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/S0002-9440(10)64075-8","article-title":"Validation of tissue microarrays for immunohistochemical profiling of cancer specimens using the example of human fibroblastic tumors","volume":"158","author":"Hoos","year":"2001","journal-title":"Am J Pathol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"9494","DOI":"10.1158\/0008-5472.CAN-10-0233","article-title":"The telomerase inhibitor imetelstat depletes cancer stem cells in breast and pancreatic cancer cell lines","volume":"70","author":"Joseph","year":"2010","journal-title":"Cancer Res."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1476-4598-10-96","article-title":"Inhibition of telomerase activity preferentially targets aldehyde dehydrogenase-positive cancer stem-like cells in lung cancer","volume":"10","author":"Serrano","year":"2011","journal-title":"Mol Cancer."},{"key":"B54","first-page":"442","article-title":"Telomerase targeted therapy in cancer and cancer stem cells","volume":"9","author":"Xu","year":"2011","journal-title":"Clin Adv Hematol Oncol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1186\/1476-4598-13-232","article-title":"Targeting DNA-PKcs and telomerase in brain tumour cells","volume":"13","author":"Gurung","year":"2014","journal-title":"Mol Cancer."},{"key":"B56","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1159\/000381346","article-title":"MST-312 alters telomere dynamics, gene expression profiles and growth in human breast cancer cells","volume":"7","author":"Gurung","year":"2014","journal-title":"J Nutrigenet Nutrigenomics."},{"key":"B57","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1016\/j.biopha.2018.07.140","article-title":"The telomerase inhibitor MST-312 synergistically enhances the apoptotic effect of doxorubicin in pre-B acute lymphoblastic leukemia cells","volume":"106","author":"Ghasemimehr","year":"2018","journal-title":"Biomed Pharmacother."},{"key":"B58","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.canlet.2008.09.012","article-title":"Telomerase inhibition induces acute ATM-dependent growth arrest in human astrocytomas","volume":"274","author":"Wong","year":"2009","journal-title":"Cancer Lett."},{"key":"B59","doi-asserted-by":"publisher","first-page":"8425","DOI":"10.1007\/s13277-015-3575-z","article-title":"MST-312 induces G2\/M cell cycle arrest and apoptosis in APL cells through inhibition of telomerase activity and suppression of NF-\u03baB pathway","volume":"36","author":"Fatemi","year":"2015","journal-title":"Tumor Biol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/S1097-2765(04)00256-4","article-title":"Telomere shortening triggers senescence of human cells through a pathway involving ATM, p53, and p21CIP1, but not p16INK4a","volume":"14","author":"Herbig","year":"2004","journal-title":"Mol Cell."}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2019.01302\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,4]],"date-time":"2019-12-04T04:56:13Z","timestamp":1575435373000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2019.01302\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,4]]},"references-count":60,"alternative-id":["10.3389\/fonc.2019.01302"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2019.01302","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,4]]},"article-number":"1302"}}